Anaemia is common before cardiac surgery and is associated with increased morbidity and mortality. The World Health Organization (WHO) definition of anaemia is lower for women than for men by 10 g.l
Introduction
Anaemia is independently associated with increased morbidity and mortality in cardiac surgical patients [1, 2] . A recent UK-wide study showed that pre-operative anaemia was common before cardiac surgery (31% of patients), and underlined that anaemia was independently associated with worse outcomes, including intensive care unit (ICU)/hospital length of stay (LOS) and mortality [3] . Anaemic patients are also more likely to be transfused [4] , which is associated with increased postoperative morbidity and mortality [5, 6] . It, therefore, seems reasonable to avoid the need for red blood cell transfusion by optimising pre-operative haemoglobin concentration (Hb) [7] . Multiple smaller retrospective studies have already shown benefit from pre-operative optimisation of anaemia, leading to reduced transfusion and shorter hospital LOS [8] [9] [10] [11] [12] . A recent consensus statement recommends optimisation of pre-operative anaemia in surgical patients [13] .
The WHO defines anaemia as Hb < 120 g.l À1 for non-pregnant adult women and < 130 g.l À1 for adult men [14] . This definition leaves women with Hb 120-130 g.l À1 , defined by us as borderline anaemia, untreated, thereby withholding the potential benefit of pre-operative optimisation [15] . In a randomised controlled trial of 512 patients undergoing cardiac surgery, Hajjar et al. showed that female sex was independently associated with red cell transfusion, and that the risk of postoperative complications increased with each unit transfused [16] . Women are generally smaller than men and have a lower circulating blood volume. Even if the Hb were similar, they would still have a lower total Hb mass and are thus more likely to be at risk of anaemia through blood loss and haemodilution during cardiac surgery [17, 18] . These women will receive more transfusions and may therefore be exposed to worse outcomes after cardiac surgery. This is not without importance, as it has been shown that women have a higher mortality after cardiac surgery compared with men [19] . Our hypothesis was that red cell transfusion rate, morbidity and mortality after cardiac surgery would be increased in women with borderline anaemia, compared with non-anaemic women. Therefore, we analysed outcomes after cardiac surgery in women according to pre-operative Hb concentration.
Methods
This retrospective observational study was approved by our local Research and Development Department, who waived the requirement for formal ethical approval and consent, as all data were routinely collected in an anonymised fashion. The study was conducted in a large UK specialist cardiothoracic hospital. We analysed prospectively collected data from all cardiac surgical patients ≥ 18 years admitted for elective routine cardiac surgery from January 2013 to April 2016. Patients were grouped according to their sex and preoperative Hb level: women < 120 g.l À1 (anaemia); 120-129 g.l À1 (defined as borderline anaemia for the purposes of this study); and ≥ 130 g.l À1 (non-anaemic).
Data were obtained from our electronic clinical information system (MetaVision, iMDsoft, Tel Aviv, Israel) with continuous clinical data recording in ICU. Baseline characteristics and outcome data were obtained from the institutional audit database (CARDS Surgical, version 1.0.0.29, Papworth Hospital NHS Trust, Cambridge, UK). These included: general patient characteristics (age, sex); type of surgery (coronary artery bypass graft surgery (CABG), valve(s), aortic or other major cardiac surgery); and the predicted hospital mortality using the logistic EuroSCORE [20] . Transfusion rates, ICU/hospital stay and postoperative mortality were recorded. Comparison between sex and Hb levels was done according to the WHO definition. In order to investigate the benefit of raising the threshold for anaemia in women to Hb < 130 g.l
À1
, we also compared women with borderline anaemia to nonanaemic women; we did not include women with severe anaemia in this analysis, as it has been previously shown that their outcomes are significantly worse [3] .
We specifically recorded the number of units of allogeneic blood transfused and where/when these units were transfused (operating theatre, ICU, surgical wards). The decision to transfuse was taken by the medical team in charge of the patients, in adherence with institutional guidelines (tranfusion trigger Hb < 70 g.l À1 during bypass, and < 80 g.l À1 after bypass and postoperatively in ICU and on the ward). Analyses were performed with GraphPad Prism â 6 for Mac OS X (GraphPad Software Inc., La Jolla, CA, USA). Categorical variables were compared using the Chi-square test. Groups were compared with the Mann-Whitney U-test for continuous data and with the Chi-square test for categorical data. Kaplan-Meier curves were plotted to investigate postoperative survival.
Results
During the study period, 1388 women and 3265 men underwent elective cardiac surgery. Baseline characteristics are shown in Table 1 . Women were significantly older and thinner and had a lower pre-operative Hb level. As expected, the logistic EuroSCORE was significantly higher in women than in men. The majority of women were admitted for valve surgery, whereas CABG was more common among men.
According to the WHO anaemia definition, 333 out of 1388 women (24%) were anaemic before surgery. Anaemic women were more likely to be transfused peri-operatively than anaemic men, 88.9% versus 66.3%, respectively (RR 1.3, 95%CI 1.3-1.4, p <0.0001). Non-anaemic women were also transfused more frequently than non-anaemic men (53.8% vs. 22.1%; RR 2.4, 95%CI 2.2-2.7; p < 0.0001).
In the overall population, ICU and hospital stay were significantly longer for women, even though ICU re-admission rates were comparable between both sexes. Women were more frequently transfused during their hospital stay (62.2% vs. 31.2%; RR 2.0, 95%CI 1.9-2.1; p < 0.0001). In-hospital mortality was not significantly different (1.6% vs. 1.1%; p = 0.1455) ( Table 2) .
Pre-operatively, 333 out of 1388 women (24%) had Hb < 120 g.l
À1
, 408 out of 1388 (29%) had Hb 120-129 g.l À1 and 647 out of 1388 (47%) had Hb
. Compared with non-anaemic women, (Hb ≥ 130 g.l
), women with borderline anaemia (Hb 120-129 g.l
) were more likely to be transfused (68.6% vs. 44.5%; RR 1.5, 95%CI 1.4-1.7; p < 0.0001) and were transfused more units of red cells, median Fig. 1 and Table 3 ). In both groups, patients were more commonly transfused during their ICU stay, followed by the intra-operative period. Patients were infrequently transfused on the surgical wards. For borderline anaemic women, 35% of units were transfused in theatres, 54% in ICU and 11% in surgical wards. For non-anaemic women, 29% of units were transfused in theatres, 63% in ICU and 8% in surgical wards. Hospital stay was significantly longer (Fig. 2) . Short-and long-term postoperative survival was comparable for both groups (Fig. 3) . If a definition of Hb < 130 g.l À1 for anaemia for women were used, 741 women (53%) would have been anaemic before surgery. After increasing the threshold for anaemia in anaemic women, women were still more likely to be transfused compared with anaemic men (77.7% vs. 66.3%; RR 1.2, 95%CI 1.1-1.3; p < 0.0001).
Discussion
We have confirmed that borderline anaemia (Hb 120-129 g.l À1 ) was very common in women presenting for cardiac surgery, as nearly a third had a Hb level in this range. These women had increased morbidity, reflected by increased red cell transfusion and prolonged hospital stay compared with non-anaemic women (Hb > 130 g.l
À1
). In addition, we found that women in general were more likely to be exposed to red cell transfusion than men, leading us to hypothesise that women are discriminated against by their lower WHO definition of anaemia (< 120 g.l À1 in women, < 130 g.l À1 in men).
Pre-operative anaemia in patients undergoing cardiac surgery [2] and major surgery [21] is clearly associated with increased morbidity and mortality. If the definition for anaemia in women was changed from < 120 g.l À1 to < 130 g.l
, a gain in health might be expected [22] . In our institution, we found that the WHO definition for anaemia only defines 24% of women as anaemic, whereas the majority of women (53%) would be considered anaemic with the proposed definition (Hb < 130 g.l À1 for both sexes), more than twice the proportion of anaemic men (21%). Muñoz et al. found a similar prevalence of anaemia (< 130 g.l À1 for both sexes) in 3342 surgical patients (53% in women vs. 23%) [23] . The higher cut-off value for anaemic women is important for several reasons. First, any reduction in pre-operative Hb below 130 g.l À1 is associated with worse outcomes, such as higher risk of transfusion and higher mortality [3] . Second, the Hb concentration does not reflect the total mass of Hb available, although it is the main trigger for transfusion strategies. Women have a lower circulating volume and thus lower total Hb mass compared with men. The degree of bleeding and the additional haemodilution caused by cardiopulmonary bypass priming is the same for women and men. Women are therefore at particular risk of developing or worsening anaemia during cardiac surgery, with the consequence of increased requirement for red cell transfusion and prolonged hospital stay. We have shown that when women have a preoperative Hb 120-129 g.l À1 before cardiac surgery, their risk of red cell transfusion was increased compared with Hb ≥ 130 g.l À1 and when transfused, more units of red cells were administered. Considering all women with Hb < 130 g.l À1 as anaemic (as is the case with men) would allow the opportunity to pre-optimise more patients before cardiac surgery, which could reduce their peri-operative exposure to red cell transfusion. Unnecessary complications and worse postoperative outcomes associated with pre-operative anaemia [21] might be avoided with this treatment, and it would also spare the use of a scarce and expensive resource [24] . In our cohort, pre-operative treatment of women with borderline anaemia might potentially have saved a significant amount of RBC. Indeed, the Figure 1 Proportions of women exposed (dark grey) and not exposed (light grey) to red blood cell transfusion (a) and median number of RBC units transfused (b). Error bars indicate interquartile range. Hb, haemoglobin; RBC, red blood cell; ****p < 0.0001. transfusion rate would have dropped from 69% to 45% and women would have been exposed to an average 1.3 units, instead of an average 1.8 units.
Overall, these results show that there may be considerable room for improvement in the pre-operative management of women undergoing cardiac surgery in particular. The vast majority of anaemic patients suffer from absolute or functional iron deficiency and may benefit from a simple treatment, for example, preoperative iron supplementation, although the evidence regarding the administration of intravenous iron (or erythropoietin) before cardiac surgery is currently still weak [25] . Women with Hb 120-130 g.l À1 have a similar incidence of absolute or functional iron deficiency as women with Hb < 120 g.l À1 leaving room for preoperative optimisation [23] . Our study adds to the growing body of evidence that WHO cut-offs for anaemia should no longer be used in the setting of surgery [22, 26, 27] . The WHO anaemia definition, published in 1959 by a WHO study group on nutritional anaemia [14] , was not designed for use in the surgical/perioperative setting. There is clearly a need for welldesigned, prospective studies in order to determine whether women would benefit from a threshold of anaemia set to Hb < 130 g.l À1 resulting in preoperative treatment including women with borderline anaemia.
The main limitation of our study is related to its retrospective design. Indeed, retrospective studies are susceptible to selection bias, which can interfere with results.
Although an association exists between pre-operative Hb levels, transfusion rates and worse outcomes, this study cannot assess their causality due to potential confounding factors (e.g. age, logistic EuroSCORE). This retrospective study shows that the WHO definition for anaemia significantly underestimates the number of women at increased risk of morbidity associated with anaemia before cardiac surgery. We propose that further research is required into the effect of treating pre-operative anaemia in both men and women using a cut-off of Hb < 130 g.l À1 to define anaemia.
